Synopsys remains a buy with growth potential and undervalued stock despite recent underperformance.

Synopsys (SNPS) is recommended as a buy due to its unique combination of steady growth, pricing power, and a currently discounted valuation following recent stock underperformance. Unlike typical SaaS companies, Synopsys operates a deeply integrated EDA business with a non-seat-based pricing model, protecting it from AI-driven software disruptions. The involvement of Elliott Investment Management, a major stakeholder, is expected to drive operational improvements and a valuation re-rating. The stock trades near the low end of its five-year price-to-earnings range, with expectations of double-digit earnings growth and pessimism already factored into the price.